Household Products

Clorox

Clorox Healthcare Launches Two Breakthrough Innovations to Address Infection Prevention Challenges

Everstar Increases Stake in Clorox (CLX) by 259.3%, Holding Worth $2.4M

Clorox Completes $1.5 Billion Senior Note Public Offering

CFRA Maintains Clorox 'Hold' Rating and Cuts Price Target

Clorox Submits Prospectus for a $1.5B Tranche Bond Issuance

Wilkins Investment Counsel Inc.大幅增持高乐氏公司股票

Citigroup Downgrades Clorox's Target Price to $97 and Maintains Neutral Rating

U.S. Bank Securities and Citibank Maintain Hold Rating on Clorox

JPMorgan Downgrades Clorox's Target Price to $95

Clorox released FY2026 9 Months earnings on April 30 After-Market EST, actual revenue USD 4.772 B, actual EPS USD 3.48

Clorox released FY2026 Q3 earnings on April 30 After-Market EST, actual revenue USD 1.67 B (forecast USD 1.668 B), actual EPS USD 1.54 (forecast USD 1.499)

Clorox Reports 2026 Q3 Earnings and Updates Outlook

Clorox to Release Q1 Earnings Report This Thursday

United Asset Strategies Inc. Significantly Reduces Holdings in Clorox

Clorox to Release FY2026 Q3 Earnings on April 30 After-Market EST, Forecast Revenue USD 1.668 B, EPS USD 1.4487

JPMorgan Downgrades Clorox to Underweight

Clorox Reports Expected Earnings

Clorox Completes Acquisition of GOJO Industries

Clorox Reports Lower-than-Expected Quarterly Earnings and Announces Dividend

Clorox signs $1 billion 364-day revolving credit agreement

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

Clorox Co. (CLX) shares fell 1.51% to $96.82 on Friday, underperforming the broader market and key competitors like Procter & Gamble, Ecolab, and Colgate-Palmolive. This marks the second consecutive day of losses for Clorox, which is now trading 26.67% below its 52-week high. Trading volume remained below the 50-day average.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

Procter & Gamble

Ecolab

Colgate

Factset Research

Clorox Co. Stock Underperforms Friday When Compared To Competitors

Andra AP fonden increased its stake in The Clorox Company (CLX) by 175% in Q4, acquiring 123,843 shares to hold 194,600 shares valued at $19.6 million. Other institutional investors like State Street and Invesco also raised their positions. Meanwhile, several analysts downgraded CLX or cut price targets, with Zacks issuing a 'strong sell' rating. Clorox recently reported quarterly EPS of $1.64, beating estimates.

Market Beat

Invesco

State Street

BNP Paribas

Goldman Sachs

JPMorgan Chase

UBS Group AG

State Street® US Equity Premium Inc ETF

GS Hldg R

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Andra AP fonden Buys 123,843 Shares of The Clorox Company $CLX

Clorox Co. (CLX) shares fell 1.03% to $98.30 on Thursday, underperforming the broader market and several competitors despite a positive trading session for major indices. This decline ended a five-day winning streak. Clorox closed 25.55% below its 52-week high of $132.03. Trading volume was below the 50-day average.

Clorox Co. Stock Underperforms Thursday When Compared To Competitors

ARCB

ARGX

TXRH

COKE

GIII

KVUE

Cooper Cos(COO) rose 8.58%, with a trading turnover 607.6 Million USD, and a year-to-date fell 17.8%. ABM Industries(ABM) rose 6.67%, with a trading turnover 59.0 Million USD, and a year-to-date rose 2%. Kimberly Clark(KMB) rose 6.28%, with a trading turnover 621.4 Million USD, and a year-to-date rose 0.7%.

Top Gainers&Losers

Cooper Cos

ABM Industries

Kimberly Clark

Arcbest

Argenx

Texas Roadhouse

Coca-Cola Bottling

G-III Apparel

Kenvue

Top 10 US Stock Gainers (6.5)

Clorox announced that CEO Linda Rendle will step down for health reasons in May 2026, transitioning to an advisory role while a board-led search for her successor continues. This leadership change occurs amid operational challenges and demand pressures. The transition adds uncertainty but aims for continuity. Key risks include competitive and pricing pressures eroding profitability, while potential catalysts involve new product launches like Clorox Healthcare Quat Alcohol wipes to defend market share.

Simplywall

Does Clorox’s (CLX) CEO Transition Reveal a Deeper Shift in Its Resilience Playbook?

Clorox Co. (CLX) shares rose 1.24% to $89.63, outperforming competitors like Procter & Gamble and Ecolab during a positive market session where the S&P 500 and Dow Jones also gained. Despite the daily rally, Clorox remains 32.11% below its 52-week high of $132.03. Trading volume was slightly below the 50-day average.

Clorox Co. Stock Outperforms Competitors On Strong Trading Day

Clorox Co. (CLX) shares fell 1.23% to $88.53 on Wednesday, underperforming the broader market as the S&P 500 and Dow Jones also declined. The stock closed 32.95% below its 52-week high of $132.03. While Clorox dropped, competitors Procter & Gamble, Ecolab, and Colgate-Palmolive also saw losses, with Colgate falling more sharply at 3.85%. This data reflects trading activity from June 3, 2026.

Clorox Co. Stock Underperforms Wednesday When Compared To Competitors

Clorox(CLX.US)